Literature DB >> 19371276

Psychological status of patients with mucopolysaccharidosis type II and their parents.

Izumi Kuratsubo1, Yasuyuki Suzuki, Koji O Orii, Tomomi Kato, Tadao Orii, Naomi Kondo.   

Abstract

BACKGROUND: The aim of the present study was to delineate the psychological status of 10 patients with the attenuated phenotype of mucopolysaccharidosis type II (MPS-II) and their parents (six fathers and five mothers) for the improvement of clinical management.
METHODS: Intellectual ability was evaluated using the Wechsler Intelligence Scale. Activities of daily living (ADL) was assessed using the Functional Independence Measure. The personality and psychiatric aspects were analyzed using the Yatabe-Guilford Personality test (Y-G test) and the Tree-Drawing Test. Mental health was assessed using the General Health Questionnaire 60 (GHQ-60) and State-Trait Anxiety Inventory (STAI).
RESULTS: Intellectual background, measured with full-scale, verbal and performance IQ, were 72.8, 76.1 and 79.3, respectively. Nine of 10 patients were not judged as having neurosis and a psychotic tendency with the Y-G test. In the tree-drawing test, many patients drew a tree without ground, suggesting that they have difficulties in making relationships with surrounding people and the community. The child patient with a psychosis pattern on the Y-G test, drew a bizarre tree, suggesting psychological problems. GHQ-60 and STAI survey indicated that the patients and their parents had higher levels of anxiety. A significant negative correlation between GHQ-60 score and ADL (R = -0.77) was identified, suggesting that the psychological status may worsen as ADL decreases.
CONCLUSIONS: Patients with MPS-II and their parents had higher risks for mental problems. Understanding psychological status is essential when providing genetic counseling or therapeutic intervention.

Entities:  

Mesh:

Year:  2009        PMID: 19371276     DOI: 10.1111/j.1442-200X.2008.02652.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  8 in total

1.  Activity of daily living for Morquio A syndrome.

Authors:  Eriko Yasuda; Yasuyuki Suzuki; Tsutomu Shimada; Kazuki Sawamoto; William G Mackenzie; Mary C Theroux; Christian Pizarro; Li Xie; Freeman Miller; Tariq Rahman; Heidi H Kecskemethy; Kyoko Nagao; Thierry Morlet; Thomas H Shaffer; Yasutsugu Chinen; Hiromasa Yabe; Akemi Tanaka; Haruo Shintaku; Kenji E Orii; Koji O Orii; Robert W Mason; Adriana M Montaño; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-04-25       Impact factor: 4.797

2.  Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation.

Authors:  Julian Tanjuakio; Yasuyuki Suzuki; Pravin Patel; Eriko Yasuda; Francyne Kubaski; Akemi Tanaka; Hiromasa Yabe; Robert W Mason; Adriana M Montaño; Kenji E Orii; Koji O Orii; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2014-11-08       Impact factor: 4.797

3.  Psychological health in adults with morquio syndrome.

Authors:  Nadia Ali; S Cagle
Journal:  JIMD Rep       Date:  2015-01-23

Review 4.  A systematic review and integrative sequential explanatory narrative synthesis: The psychosocial impact of parenting a child with a lysosomal storage disorder.

Authors:  Sadie Hassall; Debbie Michelle Smith; Stewart Rust; Anja Wittkowski
Journal:  J Inherit Metab Dis       Date:  2022-02-24       Impact factor: 4.750

5.  Development of the multi-attribute Adolescent Health Utility Measure (AHUM).

Authors:  Kathleen M Beusterien; Jean-Ezra Yeung; Francis Pang; John Brazier
Journal:  Health Qual Life Outcomes       Date:  2012-08-28       Impact factor: 3.186

Review 6.  Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issues.

Authors:  Christian J Hendriksz; Kenneth I Berger; Christina Lampe; Susanne G Kircher; Paul J Orchard; Rebecca Southall; Sarah Long; Stephen Sande; Jeffrey I Gold
Journal:  Orphanet J Rare Dis       Date:  2016-08-26       Impact factor: 4.123

7.  Reducing posttraumatic stress in parents of patients with a rare inherited metabolic disorder using eye movement desensitization and reprocessing therapy: a case study.

Authors:  Thirsa Conijn; Lotte Haverman; Frits A Wijburg; Carlijn De Roos
Journal:  Orphanet J Rare Dis       Date:  2021-03-10       Impact factor: 4.123

Review 8.  Non-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis.

Authors:  Karolina M Stepien; Andrew Bentley; Cliff Chen; M Wahab Dhemech; Edward Gee; Peter Orton; Catherine Pringle; Jonathan Rajan; Ankur Saxena; Govind Tol; Chaitanya Gadepalli
Journal:  Front Cardiovasc Med       Date:  2022-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.